Russia approves coronavirus drugs for sale

RUSSIA / FSU POLITICS - In Brief 18 Sep 2020 by Alex Teddy
Two Russian manufactured coronavirus drugs have been licensed for sale in drug stores on September 17. Both of them are version of favirpirvir which was originally an anti-flu medicine invented in Japan. The drugs are in pill form. Trials prove that recovery times are speedy. India and China have also approved it.One of the newly licensed drugs is Areplivir. It will be available on September 21. Promomed made it. Koronavir is another drug due to come on the market. It is made by R Farm. Over 50% of volunteers in the trial of this drug had their condition ameliorate after 7 days. Avifavir (a version of favirpiravir) is principally to be exported to Belarus and Kazakhstan. Japanese PM Abe said he wanted favirpiravir to be licensed in his country. Abe has now retired. Fujifilm which made it originally has not had satisfactory results with a trial yet. Letting patients with mild symptoms be treated as outpatients will reduce pressure on hospitals. The government is also banking on Sputnik V being a resounding success. An opinion poll showed 45% of people will refuse to take the vaccine.

Now read on...

Register to sample a report

Register
Sign-in
Forgot your password?
Copyright 2024 GlobalSource Partners. All rights reserved. This is prepared for GlobalSource Partners’ clients and may not be redistributed, reproduced, stored in a retrieval system, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of GlobalSource Partners. This is distributed simultaneously to our website and other portals used by GlobalSource Partners. The information herein was obtained from various sources and is believed to be reliable but GlobalSource Partners does not warrant its completeness or accuracy. Neither GlobalSource Partners nor any Country Analyst, officer or employee accepts any liability whatsoever for any direct, indirect or consequential damages or losses rising from any use of this or its contents.